A detailed history of Claraphi Advisory Network, LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Claraphi Advisory Network, LLC holds 34,880 shares of DNA stock, worth $326,825. This represents 0.02% of its overall portfolio holdings.

Number of Shares
34,880
Previous 58,948 40.83%
Holding current value
$326,825
Previous $99,000 41.41%
% of portfolio
0.02%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$1.63 - $3.52 $39,230 - $84,719
-24,068 Reduced 40.83%
34,880 $58,000
Q4 2022

Feb 13, 2023

BUY
$1.63 - $3.52 $78,420 - $169,350
48,111 Added 443.95%
58,948 $99,000
Q3 2022

Nov 14, 2022

BUY
$0.73 - $3.74 $7,911 - $40,530
10,837 New
10,837 $34,000
Q1 2022

May 12, 2022

SELL
$2.83 - $8.69 $117,385 - $360,452
-41,479 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$8.31 - $14.92 $344,690 - $618,866
41,479 New
41,479 $345,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Claraphi Advisory Network, LLC Portfolio

Follow Claraphi Advisory Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claraphi Advisory Network, LLC with notifications on news.